Cel-Sci
CVM
#9766
Rank
โ‚ฌ44.28 M
Marketcap
5,54ย โ‚ฌ
Share price
2.54%
Change (1 day)
-65.09%
Change (1 year)

Cel-Sci (CVM) - Total assets

Total assets on the balance sheet as of June 2025 : โ‚ฌ17.46 Million

According to Cel-Sci 's latest financial reports the company's total assets are โ‚ฌ17.46 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Cel-Sci - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-09-30โ‚ฌ24.23 M-15.95%
2023-09-30โ‚ฌ28.83 M-44.16%
2022-09-30โ‚ฌ51.63 M-21.22%
2021-09-30โ‚ฌ65.54 M89.62%
2020-09-30โ‚ฌ34.56 M36.41%
2019-09-30โ‚ฌ25.34 M-0.59%
2018-09-30โ‚ฌ25.49 M30.58%
2017-09-30โ‚ฌ19.52 M-12.07%
2016-09-30โ‚ฌ22.2 M-13.13%
2015-09-30โ‚ฌ25.55 M67.84%
2014-09-30โ‚ฌ15.22 M90.03%
2013-09-30โ‚ฌ8.01 M-36.12%
2012-09-30โ‚ฌ12.54 M-8.6%
2011-09-30โ‚ฌ13.72 M-50.55%
2010-09-30โ‚ฌ27.75 M-12.48%
2009-09-30โ‚ฌ31.7 M202.67%
2008-09-30โ‚ฌ10.47 M-28.06%
2007-09-30โ‚ฌ14.56 M90.99%
2006-09-30โ‚ฌ7.62 M196.31%
2005-09-30โ‚ฌ2.57 M-42.06%
2004-09-30โ‚ฌ4.44 M77.14%
2003-09-30โ‚ฌ2.5 M-34.76%
2002-09-30โ‚ฌ3.84 M-22.44%
2001-09-30โ‚ฌ4.95 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Curis
CRIS
โ‚ฌ23.74 M 35.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚ฌ0.38 B 2,095.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ77.42 B 443,153.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
โ‚ฌ0.74 B 4,172.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ34.23 B 195,885.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
โ‚ฌ165.60 B 948,041.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ1.25 B 7,084.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ5.3 M-69.65%๐Ÿ‡บ๐Ÿ‡ธ USA